Quest Diagnostics (DGX) Tops Q4 EPS by 2c, Offers Guidance

Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $1.40, $0.02 better than the analyst estimate of $1.38. Revenue for the quarter came in at $1.94 billion versus the consensus estimate of $1.94 billion.

GUIDANCE:

Quest Diagnostics sees FY2018 EPS of $6.50-$6.70, versus the consensus of $6.61.

For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• UBS Upgrades Apollo Tyres (APTY:IN) to Buy
• ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)